TSP Advanced Technologies #TSP – Notice of 2025 AGM November 17, 2025 – Posted in: Blog, TSP Advanced Technologies

TSP Advanced Technologies plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that notice of the Company’s 2025 annual general meeting (“2025 AGM”) has been sent to shareholders. The 2025 AGM will be held at Regus, Crawley, Gatwick Airport Manor Royal, Churchill Court 3, Crawley, RH10 9LU on 10 December 2025 at 11:00 a.m. A copy of the notice of the 2025 AGM, along with the form of proxy, will be…

Continue reading

TruSpine Technologies #TSP – Major Shareholding October 16, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies announces that Martin Armstrong and Cheam Marketing Consultants now own 9,741,333 shares (5.20%) of the company. Breakdown shown on TR1 form below:     TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Truspine Technologies PLC 1b. Please…

Continue reading

TruSpine Technologies #TSP – Final Results & Update re Suspension October 14, 2025 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the spinal (vertebral) stabilisation market, reports its full year results for the year ended 29 March 2025. Suspension Following publication of these results, the Company’s shares is anticipated to be restored to trading on the AQSE Growth Market with effect from 8:00a.m. on 15 October 2025 The Company continues to be in a pre-revenue development phase and remains loss-making at this stage of its…

Continue reading

TruSpine Technologies #TSP – Result of GM & Change of Name August 22, 2025 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that at its GM held earlier today all resolutions were duly passed.  Change of Name Once the change of the Company’s name to TSP Advanced Technologies plc takes effect, the Company’s ticker for AQSE will remain as TSP. The Company’s new website address, containing the information required to be published pursuant to Rule 4.14 of the AQSE Growth Market Access…

Continue reading

TruSpine Technologies #TSP – Notice of GM. Proposed Adoption of Bitcoin Treasury Policy, IP Expansion & Change of Name August 4, 2025 – Posted in: Blog, TruSpine Plc (TSP)

London, United Kingdom – 4 August 2025 – TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that the Company has sent a notice of general meeting (“GM”) to shareholders. The GM will be held at Regus, Crawley, Gatwick Airport Manor Royal, Churchill Court 3, Crawley, RH10 9LU on 22 August 2025 at 11:00 a.m. The Directors of TruSpine wish to seek shareholder approval for its recently announced decisions…

Continue reading

TruSpine #TSP – Engagement to support Bitcoin Treasury Policy July 3, 2025 – Posted in: Blog, TruSpine Plc (TSP)

London, United Kingdom – 3rd July, 2025 – TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has engaged a fintech advisory company to provide support to the Board in the implementation of its Bitcoin Treasury Policy. The Company announced on 25th June that it was actively pursuing a Bitcoin Treasury Policy.  In order to ensure that this is implemented in a best of breed fashion, achieves…

Continue reading

TruSpine #TSP – Bitcoin Treasury Policy June 25, 2025 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it actively pursuing the implementation of a Bitcoin Treasury Policy. The Company will continue to focus on its core business, whilst growing a bitcoin treasury to facilitate the funding of such business over the medium-term. The Company’s Bitcoin Treasury Policy will align with the Directors’ views that bitcoin provides a means to preserve value over time and serve as…

Continue reading

#TSP TruSpine Plc – Update on AQSE Fine May 20, 2025 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that, following a Warning Notice issued by Aquis Stock Exchange (“AQSE”) on 1 May 2025, AQSE Regulation has decided to enforce £15,000 of the £165,000 suspended element of the £215,000 fine originally imposed on the Company under the Disciplinary Decision Notice published on 16 August 2023.   The fine will be settled from the Company’s existing cash resources. The remaining…

Continue reading

TruSpine #TSP – Investor Webinar April 7, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, is pleased to announce a live Webinar hosted by Geoff Miller, CEO of the Company, via the Company’s recently updated Investor website on Friday, 11 April 2025, at 10:00 AM BST. This session is open to all existing and prospective shareholders. Questions can be submitted in advance via the webinar page until Wednesday, 9 April 2025 at 10:00 AM BST, or…

Continue reading

TruSpine #TSP – Notice of 2024 AGM March 17, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that notice of the Company’s 2024 annual general meeting (“2024 AGM”) has been sent to shareholders. The 2024 AGM will be held at Regus, Crawley, Gatwick Airport Manor Royal, Churchill Court 3, Crawley, RH10 9LU  on 10 April 2025 at 11:00 am. A copy of the notice of the 2024 AGM, along with the form of proxy, will be shortly…

Continue reading